Structural and functional analysis of amino-terminal enhancer of split in androgen-receptor-driven transcription

Biochemical Journal

Volumn 427, Issue 3, 2010, Pages 499-511

  Zhang, Yiming ^a   Gao, Shen ^b   Wang, Zhengxin ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Amino terminal enhancer of split (AES); Androgen; Androgen receptor (AR); Co repressor; Nuclear receptor; Transcription

Indexed keywords

ANDROGEN RECEPTOR (AR); ANDROGEN RECEPTORS; ANDROGEN-DEPENDENT; C-TERMINAL DOMAINS; COREPRESSORS; DNA INTERACTION; INHIBITORY DOMAINS; INHIBITORY EFFECT; MOLECULAR MECHANISM; N-TERMINAL DOMAINS; N-TERMINALS; NUCLEAR RECEPTORS; PROSTATE CANCER CELLS; REGULATORY DOMAIN; TRANSCRIPTIONAL ACTIVITY; TRANSIENT TRANSFECTION;

ARGON; GENES; NUCLEIC ACIDS; PLANTS (BOTANY); PROTEINS;

TRANSCRIPTION;

AMINO TERMINAL ENHANCER OF SPLIT PROTEIN; ANDROGEN; ANDROGEN RECEPTOR; DNA; LUCIFERASE; NUCLEAR RECEPTOR COREPRESSOR; UNCLASSIFIED DRUG; AES PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DIMERIZATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN INTERACTION; STRUCTURE ANALYSIS; TRANSIENT TRANSFECTION; ANIMAL; ARMYWORM; CELL LINE; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; GEL MOBILITY SHIFT ASSAY; GENETICS; METABOLISM; PHYSIOLOGY; PROSTATE TUMOR; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPODOPTERA; TRANSCRIPTION, GENETIC;

EID: 77951237082     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20091631     Document Type: Article

References (46)

1. Brinkmann, A. O., Blok, L. J., de Ruiter, P. E., Doesburg, P., Steketee, K., Berrevoets, C. A. and Trapman, J. (1999) Mechanisms of androgen receptor activation and function. J. Steroid Biochem. Mol. Biol. 69, 307-313
2. Janne, O. A., Moilanen, A. M., Poukka, H., Rouleau, N., Karvonen, U., Kotaja, N., Hakli, M. and Palvimo, J. J. (2000) Androgen-receptor-interacting nuclear proteins. Biochem. Soc. Trans. 28, 401-405
3. Heinlein, C. A. and Chang, C. (2002) Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 23, 175-200
4. Gelmann, E. P. (2002) Molecular biology of the androgen receptor. J. Clin. Oncol. 20, 3001-3015
5. Tsai, M. J. and O'Malley, B. W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63, 451-486
6. Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. and Evans, R. M. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839 (Pubitemid 126663112)
7. Craft, N., Shostak, Y., Carey, M. and Sawyers, C. L. (1999) A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat. Med. 5, 280-285
8. Dehm, S. M. and Tindall, D. J. (2005) Regulation of androgen receptor signaling in prostate cancer. Expert Rev. Anticancer Ther. 5, 63-74
9. So, A., Gleave, M., Hurtado-Col, A. and Nelson, C. (2005) Mechanisms of the development of androgen independence in prostate cancer. World J. Urol. 23, 1-9
10. Quigley, C. A., De Bellis, A., Marschke, K. B., el-Awady, M. K., Wilson, E. M. and French, F. S. (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 16, 271-321
11. Xu, W. (2005) Nuclear receptor coactivators: the key to unlock chromatin. Biochem. Cell Biol. 83, 418-428
12. Burd, C. J., Morey, L. M. and Knudsen, K. E. (2006) Androgen receptor corepressors and prostate cancer. Endocr. Relat. Cancer. 13, 979-994
13. Dedhar, S., Rennie, P. S., Shago, M., Hagesteijn, C. Y., Yang, H., Filmus, J., Hawley, R. G., Bruchovsky, N., Cheng, H., Matusik, R. J. et al. (1994) Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367, 480-483
14. Sato, N., Sadar, M. D., Bruchovsky, N., Saatcioglu, F., Rennie, P. S., Sato, S., Lange, P. H. and Gleave, M. E. (1997) Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP. J. Biol. Chem. 272, 17485-17494
15. Lee, D. K. and Chang, C. (2003) Endocrine mechanisms of disease: expression and degradation of androgen receptor: mechanism and clinical implication. J. Clin. Endocrinol. Metab. 88, 4043-4054
16. Poukka, H., Karvonen, U., Yoshikawa, N., Tanaka, H., Palvimo, J. J. and Janne, O. A. (2000) The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. J. Cell. Sci. 113, 2991-3001
17. Baniahmad, A. (2005) Nuclear hormone receptor co-repressors. J. Steroid Biochem. Mol. Biol. 93, 89-97
18. Wang, L., Hsu, C. L. and Chang, C. (2005) Androgen receptor corepressors: an overview. Prostate 63, 117-130
19. 2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J. Biol. Chem. 273, 92-101
20. Langley, E., Zhou, Z. X. and Wilson, E. M. (1995) Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem. 270, 29983-29990
21. 2-terminal and carboxyl-terminal interaction in the human androgen receptor. Mol. Genet. Metab. 75, 293-298
22. Wilson, E. M., He, B. and Langley, E. (2003) Methods for detecting domain interactions in nuclear receptors. Methods Enzymol. 364, 142-152
23. Qi, W., Wu, H., Yang, L., Boyd, D. D. and Wang, Z. (2007) A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression. EMBO J. 26, 65-75
24. Bai, S., He, B. and Wilson, E. M. (2005) Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Mol. Cell. Biol. 25, 1238-1257
25. Shenk, J. L., Fisher, C. J., Chen, S. Y., Zhou, X. F., Tillman, K. and Shemshedini, L. (2001) p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. J. Biol. Chem. 276, 38472-38479
26. Hsu, C. L., Chen, Y. L., Ting, H. J., Lin, W. J., Yang, Z., Zhang, Y., Wang, L., Wu, C. T., Chang, H. C., Yeh, S., Pimplikar, S. W. and Chang, C. (2005) Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Mol. Endocrinol. 19, 350-361
27. Yu, X., Li, P., Roeder, R. G. and Wang, Z. (2001) Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split. Mol. Cell Biol. 21, 4614-4625
28. Chen, G. and Courey, A. J. (2000) Groucho/TLE family proteins and transcriptional repression. Gene 249, 1-16
29. Chen, G., Nguyen, P. H. and Courey, A. J. (1998) A role for Groucho tetramerization in transcriptional repression. Mol. Cell. Biol. 18, 7259-7268
30. Mallo, M., Gendron-Maguire, M., Harbison, M. L. and Gridley, T. (1995) Protein characterization and targeted disruption of Grg, a mouse gene related to the groucho transcript of the Drosophila enhancer of split complex. Dev. Dyn. 204, 338-347
31. Wang, W. F., Wang, Y. G., Reginato, A. M., Plotkina, S., Gridley, T. and Olsen, B. R. (2002) Growth defect in Grg5 null mice is associated with reduced Ihh signaling in growth plates. Dev. Dyn. 224, 79-89
32. Allen, T., van Tuyl, M., Iyengar, P., Jothy, S., Post, M., Tsao, M. S. and Lobe, C. G. (2006) Grg1 acts as a lung-specific oncogene in a transgenic mouse model. Cancer Res. 66, 1294-1301
33. Gao, S., Liu, G.-Z. and Wang, Z. (2004) Modulation of androgen receptor-dependent transcription by resveratrol and genistein in prostate cancer cells. Prostate 59, 214-225 (Pubitemid 38481232)
34. Hosohata, K., Li, P., Hosohata, Y., Qin, J., Roeder, R. G. and Wang, Z. (2003) Purification and identification of a novel complex which is involved in androgen receptor-dependent transcription. Mol. Cell. Biol. 23, 7019-7029
35. Liu, G.-Z., Wang, H. and Wang, Z. (2003) Identification of a highly conserved domain in the androgen receptor that suppresses the DNA-binding domain-DNA interactions. J. Biol. Chem. 278, 14956-14960
36. Yu, X., Li, P., Roeder, R. G. and Wang, Z. (2001) Inhibition of androgen receptor-mediated transcription by amino-terminal enhancer of split. Mol. Cell. Biol. 21, 4614-4625
37. Zhou, L., Wu, H., Lee, P. and Wang, Z. (2006) Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells. J. Mol. Endocrinol. 37, 283-300
38. Liu, G. Z., Wang, H. and Wang, Z. (2003) Identification of a highly conserved domain in the androgen receptor that suppresses the DNA-binding-domain-DNA interactions. J. Biol. Chem. 278, 14956-14960
39. -ΔΔCT method. Methods 25, 402-408
40. Gao, S., Lee, P., Wang, H., Gerald, W., Adler, M., Zhang, L., Wang, Y. F. and Wang, Z. (2005) The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol. Endocrinol. 19, 1792-1802
41. Pinto, M. and Lobe, C. G. (1996) Products of the grg(Groucho-related gene) family can dimerize through the amino-terminal Q domain. J. Biol. Chem. 271, 33026-33031
42. Ren, B., Chee, K. J., Kim, T. H. and Maniatis, T. (1999) PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13, 125-137 (Pubitemid 29045121)
43. He, B., Kemppainen, J. A. and Wilson, E. M. (2000) FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275, 22986-22994
44. Liu, D., Ishima, R., Tong, K. I., Bagby, S., Kokubo, T., Muhandiram, D. R., Kay, L. E., Nakatani, Y. and Ikura, M. (1998) Solution structure of a TBP-TAF(II)230 complex: protein mimicry of the minor groove surface of the TATA box unwound by TBP. Cell 94, 573-583
45. Jayaraman, J. and Prives, C. (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81, 1021-1029
46. Hupp, T. R., Sparks, A. and Lane, D. P. (1995) Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-245